Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel route for ETP natural product Epicoccin G using photo-oxidation and dimerization. Cost-effective scale-up for pharmaceutical intermediates.
Novel synthetic route for I-D1-6 diabetes inhibitor intermediate. Scalable process reduces raw material dependency and ensures supply chain stability for global pharmaceutical manufacturers.
Patent CN1259122A details a novel asymmetric Birch reduction for chiral 3,4-dehydroprolines, offering superior yields and eliminating toxic reagents for cost-effective API manufacturing.
Novel copper-catalyzed route for thiotrifluoroacetamide intermediates ensures high purity and scalable manufacturing for global pharmaceutical supply chains and cost reduction.
Novel route for dexamethasone using tetraene-pregna-3,20-diketone reduces steps and cost for pharmaceutical intermediate manufacturing.
Novel telescoped synthesis reduces costs and simplifies purification for high-purity sulfachloropyridazine sodium production suitable for veterinary applications.
Novel solid-phase synthesis reduces side reactions and improves purity for scalable amylin analogue manufacturing supply chains globally.
Patent CN100567497C details a novel two-phase enzymatic route for high-purity chiral 2-butanol. This method offers significant supply chain stability and cost reduction advantages.
Patent CN115819493A reveals a novel acid-base washing method improving crude peptide purity by approximately 30%, offering cost-effective manufacturing for GLP-1 analogs.
Novel fragment condensation method reduces impurities and production costs significantly. Reliable supply chain partner for high purity polypeptide manufacturing processes.
Patent CN115536626B reveals high-yield racemic fraxinellone synthesis. Offers scalable supply chain solutions and cost reduction for pharmaceutical manufacturing partners seeking reliable intermediates.
Patent CN110964097B details a high-yield solid-phase fragment method for Exenatide, achieving over 99.7% purity and significantly reducing manufacturing costs.
Advanced all-solid-phase synthesis of Thymalfasin using amino resin and DMB-modified dipeptides. Delivers high purity and yield for reliable pharmaceutical intermediates supply.
Novel non-hydrogenation route for 2'-hydroxydihydrochalcone using 2-phenyl-benzothiazoline. Safe, scalable, cost-effective API intermediate manufacturing.
Patent CN110746340A reveals a high-yield synthesis of 5-methoxy-2-methyltryptamine via nitroethane condensation. Offers cost-effective scaling for pharmaceutical intermediates.
Novel copper-catalyzed synthesis offers high purity and scalable production for antiviral pharmaceutical intermediates supply chain optimization and significant cost reduction benefits.
Patent CN110894227A details a novel two-fragment solid-phase synthesis for Liraglutide, offering higher purity and reduced oily intermediates for reliable pharmaceutical manufacturing.
Patent CN116874438A reveals one-pot synthesis enhancing purity and yield. Offers substantial cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Novel liquid-phase synthesis for Tenipout peptide using soluble hydrophobic tags. Enhances purity and scalability for pharmaceutical intermediates manufacturing supply chains.
Novel nickel-catalyzed route for Ruxolitinib key intermediate. Reduces cost, eliminates palladium, ensures high purity for API manufacturing.